DUSSELDORF, Germany – As Europe’s largest international partnering conference for diagnostics, digital health, regenerative medicine, and research tools, DxPx 2020 established a powerful networking ecosystem for startups, established companies, and investors during a pivotal year for global healthcare.
To adapt to global challenges, the 2020 edition launched as a highly successful hybrid event , seamlessly blending analog and digital formats.
This allowed international participants to safely evaluate investment opportunities, M&A options, licensing agreements, and R&D partnerships via smartphone, tablet, or computer from anywhere across the globe.
Unprecedented Investor Presence and Global Reach Building on the success of its 400-participant debut the previous year, DxPx 2020 offered access to more active investors focusing on diagnostics and precision medicine than any other partnering conference of its time.
